Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001013762-25-003930
Filing Date
2025-03-28
Accepted
2025-03-28 14:17:51
Documents
7
Effectiveness Date
2025-03-28

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0235361-s8_chinasxt.htm S-8 54278
2 2025 EQUITY INCENTIVE PLAN ea023536101ex4-2_chinasxt.htm EX-4.2 103890
3 OPINION OF CAMPBELLS ea023536101ex5-1_chinasxt.htm EX-5.1 28641
4 CONSENT OF ZH CPA, LLC ea023536101ex23-1_chinasxt.htm EX-23.1 3816
5 FILING FEE TABLE ea023536101ex-fee_chinasxt.htm EX-FILING FEES 12103
6 GRAPHIC ex5-1_001.jpg GRAPHIC 15133
7 GRAPHIC ex23-1_001.jpg GRAPHIC 19995
  Complete submission text file 0001013762-25-003930.txt   252408
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-286212 | Film No.: 25784532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)